Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
MYLAN PHARMACEUTICALS INC. et al v. UNITED STATES FOOD AND DRUG ADMINISTRATION
Case Number:
1:11-cv-00566
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
-
May 02, 2011
FDA Gets Mylan Suit Over Generic Lipitor Tossed
A federal judge in Washington on Monday tossed Mylan Pharmaceuticals Inc.'s suit to compel the U.S. Food and Drug Administration to weigh in on Ranbaxy Laboratories Ltd.'s exclusivity provision for marketing a generic version of Lipitor.
-
April 28, 2011
FDA Must Act Quickly On Ranbaxy Lipitor ANDA: Mylan
Mylan Pharmaceuticals Inc. asked a Washington federal judge on Thursday not to toss its suit seeking to compel the U.S. Food and Drug Administration to remove the exclusivity provision from Ranbaxy Laboratories Ltd.'s dormant first-filed abbreviated new drug application for Lipitor.
-
April 07, 2011
FDA Blasts Mylan Suit Over Generic Lipitor Exclusivity
The U.S. Food and Drug Administration on Monday asked a Washington court to throw out a suit by Mylan Pharmaceuticals Inc. seeking to force the agency to strip Ranbaxy Laboratories Ltd. of the exclusive right to sell generic Lipitor, a cholesterol drug.